Production (Stage)
Orchestra BioMed Holdings, Inc.
OBIO
$2.72
-$0.01-0.37%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 243.08% | -74.37% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 243.08% | -74.37% | |||
| Cost of Revenue | -24.14% | -14.71% | |||
| Gross Profit | 322.56% | -78.78% | |||
| SG&A Expenses | 6.13% | 4.15% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 16.89% | -2.30% | |||
| Operating Income | -13.46% | -2.05% | |||
| Income Before Tax | -16.09% | -4.73% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -16.09% | -4.73% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -16.09% | -4.73% | |||
| EBIT | -13.46% | -2.05% | |||
| EBITDA | -13.53% | -2.01% | |||
| EPS Basic | -15.57% | -3.51% | |||
| Normalized Basic EPS | -15.57% | -3.51% | |||
| EPS Diluted | -15.57% | -3.51% | |||
| Normalized Diluted EPS | -15.57% | -3.51% | |||
| Average Basic Shares Outstanding | 0.45% | 1.18% | |||
| Average Diluted Shares Outstanding | 0.45% | 1.18% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||